Pliant Therapeutics (PLRX) Retained Earnings (2019 - 2025)
Pliant Therapeutics (PLRX) has disclosed Retained Earnings for 7 consecutive years, with -$859.4 million as the latest value for Q4 2025.
- On a quarterly basis, Retained Earnings fell 21.03% to -$859.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$859.4 million, a 21.03% decrease, with the full-year FY2025 number at -$859.4 million, down 21.03% from a year prior.
- Retained Earnings was -$859.4 million for Q4 2025 at Pliant Therapeutics, down from -$835.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $159000.0 in Q1 2025 to a low of -$859.4 million in Q4 2025.
- A 5-year average of -$279.7 million and a median of -$177.9 million in 2021 define the central range for Retained Earnings.
- Peak YoY movement for Retained Earnings: plummeted 40974.61% in 2024, then surged 100.03% in 2025.
- Pliant Therapeutics' Retained Earnings stood at -$215.1 million in 2021, then skyrocketed by 99.09% to -$2.0 million in 2022, then crashed by 25423.39% to -$499.7 million in 2023, then plummeted by 42.08% to -$710.1 million in 2024, then dropped by 21.03% to -$859.4 million in 2025.
- Per Business Quant, the three most recent readings for PLRX's Retained Earnings are -$859.4 million (Q4 2025), -$835.8 million (Q3 2025), and -$1000.0 (Q2 2025).